Publications

Export 48 results:
Auteur Title [ Type(Desc)] Année
Filtres: Auteur is John CS Breitner  [Enlever les filtres]
Journal Article
Chuang Y-F, An Y, Bilgel M, Wong DF, Troncoso JC, O'Brien RJ, Breitner JCS, Ferruci L, Resnick SM, Thambisetty M.  2015.  Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.. Mol Psychiatry.
Breitner JCS.  2014.  Mild cognitive impairment and progression to dementia: new findings.. Neurology. 82(4):e34-5.
Binette APichet, Gonneaud J, Vogel JW, La Joie R, Rosa-Neto P, D Collins L, Poirier J, Breitner JCS, Villeneuve S, Vachon-Presseau E.  2020.  Morphometric network differences in ageing versus Alzheimer's disease dementia.. Brain. 143(2):635-649.
Tullo S, Patel R, Devenyi GA, Salaciak A, Bedford SA, Farzin S, Wlodarski N, Tardif CL, Breitner JCS, Chakravarty MM.  2019.  MR-based age-related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan.. Hum Brain Mapp.
Heneka MT, Carson MJ, Khoury JEl, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM et al..  2015.  Neuroinflammation in Alzheimer's disease.. Lancet Neurol. 14(4):388-405.
Meyer P-F, Labonte A, Rosa-Neto P, Poirier J, Breitner JCS.  2019.  No apparent effect of naproxen on CSF markers of innate immune activation.. Ann Clin Transl Neurol. 6(6):1127-1133.
Breitner JCS.  2015.  Observations on DSM-5 Mild Neurocognitive Disorder vs. its predecessor, Mild Cognitive Impairment.. Acta Psychiatr Scand. 131(1):15-7.
Lafaille-Magnan M-E, Poirier J, Etienne P, Tremblay-Mercier J, Frenette J, Rosa-Neto P, Breitner JCS.  2017.  Odor identification as a biomarker of preclinical AD in older adults at risk.. Neurology. 89(4):327-335.
Zuo X-N, Anderson JS, Bellec P, Birn RM, Biswal BB, Blautzik J, Breitner JCS, Buckner RL, Calhoun VD, F Castellanos X et al..  2014.  An open science resource for establishing reliability and reproducibility in functional connectomics.. Sci Data. 1:140049.
Villeneuve S, Vogel JW, Gonneaud J, Binette APichet, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS et al..  2018.  Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.. JAMA Neurol.
Breitner JCS, Poirier J, Etienne PE, Leoutsakos JM.  2016.  Rationale and Structure for a New Center for Studies on Prevention of Alzheimer's Disease (StoP-AD).. J Prev Alzheimers Dis. 3(4):236-242.
Tardif CL, Devenyi GA, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner JCS, Chakravarty MM.  2018.  Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.. Hum Brain Mapp. 39(2):971-984.
Colby-Milley J, Cavanagh C, Jego S, Breitner JCS, Quirion R, Adamantidis A.  2015.  Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.. PLoS One. 10(6):e0130177.
Verfaillie SCJ, Binette APichet, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS et al..  2017.  Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease.
Verfaillie SCJ, Binette APichet, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS et al..  2018.  Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.. Biol Psychiatry Cogn Neurosci Neuroimaging. 3(5):463-472.
Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JCS, Bellec P.  2015.  Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease.. Sci Data. 2:150043.
Zimmer ERigon, Leuzy A, Benedet ALessa, Breitner JCS, Gauthier S, Rosa-Neto P.  2014.  Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.. J Neuroinflammation. 11:120.
Chuang Y-F, Breitner JCS, Chiu Y-L, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K et al..  2014.  Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study.. Neurobiol Aging. 35(11):2429-35.
Dadar M, Pascoal TA, Manitsirikul S, Misquitta K, Tartaglia C, Breitner JCS, Rosa-Neto P, Carmichael O, DeCarli C, D Collins L.  2017.  Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's Disease.. IEEE Trans Med Imaging.
Peterson D, Munger C, Crowley J, Corcoran C, Cruchaga C, Goate AM, Norton MC, Green RC, Munger RG, Breitner JCS et al..  2014.  Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.. Alzheimers Dement. 10(3):366-71.
Steinberg M, Hess K, Corcoran C, Mielke MM, Norton M, Breitner JCS, Green R, Leoutsakos J, Welsh-Bohmer K, Lyketsos C et al..  2014.  Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.. Int J Geriatr Psychiatry. 29(2):153-9.
Köbe T, Binette APichet, Vogel JW, Meyer P-F, Breitner JCS, Poirier J, Villeneuve S.  2021.  Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes.. Neuroimage. 231:117832.
Breitner JCS.  2014.  What should we do if we were wrong and Alzheimer was right? Int Psychogeriatr. 26(1):3-6.

Pages